incubation at 378C in calf serum, more than 80% of the radioactivity was still bound to the microspheres.
] + has been widely studied for radiopharmaceutical application because of the high substitution stability of its three CO ligands and the substitution lability of the coordinated water molecules [13, 14] . The rhenium tricarbonyl complex [ 188 Re(CO) 3 (H 2 O) 3 ] + has also been studied. It is more difficult to prepare than the technetium carbonyl complex because rhenium requires harsher conditions to be reduced from its original oxidation state, + VII, to lower oxidation states and it has a higher tendency to reoxidize [15] .
In this study, we used biodegradable polyester microspheres made from poly(lactic acid) (PLA) [16] with a mean particle diameter of 2 mm. A particle size of 2-5 mm seems to be ideal to reduce leakage from the treated joint [10] . In order to radiolabel microspheres with a rapid and mild method, the surface of PLA microspheres was covalently derivatized with histidine to be labelled with the organometallic aqua ion [ 188 Re(CO) 3 4 (85%) was added to the vial and incubated in a water bath at 50-901C for 10-30 min. A 20 ml syringe was used to keep the balance of H 2 gas. Both colloidal and free 188 Re could be removed using a small Sep-Pak column (Plus QMA; Waters Co.).
Quality control
The chelation efficiency of [ 188 Re(CO) 3 (H 2 O) 3 ] + was determined by thin layer chromatography (TLC) and high-performance liquid chromatography (HPLC). The TLC system consisted of a GF 254 silica gel glass plate as stationary phase and CH 3 OH/hydrochloric acid (36%) (99:1) as mobile phase. The plates were scanned with a Bioscan AR-2000 radioanalyser. HPLC analyses were performed on a Dionex P680 system equipped with a PDA-100 photodiode array detector and a Bioscan Flowcount radiometric detector. HPLC solvents consisted of methanol (solvent A) and 0.05 M TEAP (triethylammonium phosphate solution) buffer, pH 2.25 (solvent B). HPLC was performed using a C18 reversed phase column (10 mm, 300 Â 3.9 mm, Waters Co.) with the following parameters: 0-3 min, 100% B; 3-9 min, 75% B and 25% A; 9-20 min, 66% B and 34% A; 20-22 min, 100% A; 22-25 min, 75% B and 25% A; 25-30 min, 100% B.
Radiolabelling of PLA microspheres with [ 188 Re(CO) 3 (H 2 O) 3 ] + Biodegradable PLA microspheres were prepared by a solvent evaporation method [16] and yielded a mean particle size of 2 mm, as determined on a multichannel particle size analyser COULTER Multisizer II (Beckman Coulter, Fullerton, California, USA). In summary, 1 g of poly(L-lactic acid) with a molecular weight of 2000 (Resomer 104, Boehringer Ingelheim, Germany) was dissolved in 4 ml of chloroform and added to 320 ml of a heavily stirred solution of 1% polyvinyl alcohol in water. After 45 min of stirring, the microspheres were washed several times with distilled water. where A s is the radioactivity of the supernatant, and A t is the total radioactivity before separation.
One millilitre of new-born calf serum or phosphate buffered saline (PBS, pH 7.4) was added to the labelled microspheres and incubated at 371C in a shaking water bath. At time points of 1 h, and 1, 2 and 3 days, the supernatant was removed and the labelling efficiency determined.
Results and discussion

Analysis of chelation efficiency
The TLC system for the analysis of the chelation efficiency of [ 188 Re(CO) 3 (H 2 O) 3 ] + always showed four peaks ( Fig. 1(b) (Fig. 1(b) ). Both colloidal and free 188 Re could be removed using a small Sep-Pak column ( Fig.  1(c) ). The chelation efficiency was calculated using the sum radioactivity of the two middle peaks divided by the total radioactivity in TLC (Fig. 1) . -(20 ± 5%, RT = 9-10 min), which were the same as described by Schibli et al. [15] (Fig. 2) . 3 ] + can be stored at room temperature for the radiolabelling of microspheres or other compounds, we also analysed the chelation efficiency at different time points after preparation (i.e., 1, 3, 5 and 24 h after its preparation) (Fig. 6) . After Re radiopharmaceuticals because it binds readily to histidine groups which are often present in peptides and proteins.
The final chelation efficiency of higher than 95% with radioactivity concentrations greater than 74 MBq Á ml -1 under the optimal reaction conditions was appropriate for radiolabelling PLA microspheres. not very useful for radiolabelling with the 188 Re carbonyl complex. The labelling efficiencies of 2 mg of PLA-his microspheres in 0.1, 0.5 and 1 ml of total volume were 92.66 ± 0.1%, 86.18 ± 4.04% and 70.48 ± 11.01%, respectively. With 4, 6 and 8 mg of microspheres, the radiolabelling efficiencies were 87.47 ± 0.04%, 87.92 ± 0.89% and 82.52 ± 7.04% in 1 ml of solvent. From these results, we chose radiolabelling of 4 mg of PLA microspheres in 1 ml as our procedure for further studies (Figs 7 and 8) .
In-vitro stability of PLA-his microspheres
The serum stability of PLA-his microspheres is slightly lower than the stability measured in PBS, with about 80% of the radioactivity still bound to the microspheres after 3 days (Fig. 9) .
Using the optimized reaction conditions, the radiolabelling efficiency of PLA-his microspheres with [ 188 Re (CO) 3 (H 2 O) 3 ] + exceeds 92%. In contrast, radiolabelling of the control microspheres containing -COOH and 
(H 2 O) 3 ]
+ using an effective method with high radiolabelling efficiency and serum stability. When made into a kit (which has still to be perfected) that contains one vial of the histidine-derivatized microspheres and a second vial of the educts for the [ 188 Re(CO) 3 ] + core preparation, it is thought that such microspheres will be useful as a radiation synovectomy agent for the treatment of chronically inflamed arthritic joints. Being biodegradable will allow them to disappear after having delivered their radiation dose without inducing long-term irritation and chronic effects. A rabbit experiment to test the 188 Re labelled microspheres is under way. But there are also other possible applications of such radioactive microsphere preparations, such as the treatment of cancer after direct injection into the tumour or by injection of larger (20-30 mm) microspheres made from the same material which then radioembolize the arterial supply of the tumour [21] . Furthermore, magnetic targeting is also possible with smaller particles (1 mm or less) that contain magnetic nanoparticles [22] . In this way, liver, lung, and head and neck tumours, for example, could be targeted by placing a magnet above the tumour, and then injecting the radioactive particles into a patient's blood supply. In new-born calf serum In PBS (0.2M, pH 7.4) 
